Project Number 1R44AG065152-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Open-label extension of a 3-month blinded clinical trial of PTI-125 Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator BURNS, LINDSAY H. Principal Investigator First Name LINDSAY H. Principal Investigator Last Name BURNS Awardee Organization PAIN THERAPEUTICS, INC. Awardee State Texas Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-18-187: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $2,499,896 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
